The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged

The transcriptomic profile of CD138⁺ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged

Haematologica. 2019 Oct;104(10):e465-e469. doi: 10.3324/haematol.2018.209999. Epub 2019 Mar 7.

Paola Storti^{1

2}, Luca Agnelli^{3

4}, Benedetta Dalla Palma^{5

6}, Katia Todoerti^{3

4}, Valentina Marchica^{5

2}, Fabrizio Accardi^{5

6}, Gabriella Sammarelli⁶, Federica Deluca⁵, Denise Toscani⁵, Federica Costa⁵, Emanuela Vicario⁵, Giannalisa Todaro⁵, Eugenia Martella⁷, Antonino Neri^{3

4}, Nicola Giuliani^{8

2

6}

¹ Department of Medicine and Surgery, University of Parma, Parma paola.storti@unipr.it.
² CORELAB Azienda Ospedaliero-Universitaria di Parma, Parma.
³ Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
⁴ Department of Oncology and Hemato-oncology, University of Milan, Milan.
⁵ Department of Medicine and Surgery, University of Parma, Parma.
⁶ Hematological Unit Azienda Ospedaliero-Universitaria di Parma, Parma.
⁷ Pathology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
⁸ Department of Medicine and Surgery, University of Parma, Parma nicola.giuliani@unipr.it.

No abstract available